Search research articles
Contact Us
Filters
Showing results (71-80 of 166) with videos related to
Page
of 17
Sort By:
The Journal of Experimental Medicine
|
April 1, 2022
miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease
Carlos Perez-Sanchez, Ariana Barbera Betancourt, Paul A Lyons, et al.
Nature Immunology
|
February 27, 2007
FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis
Zou Xiang, Antony J Cutler, Rebecca J Brownlie, et al.
BMC Medical Genetics
|
March 7, 2009
Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis
Edward J Carr, Menna R Clatworthy, Christopher E Lowe, et al.
Genome Medicine
|
November 26, 2020
Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases
Oliver S Burren, Guillermo Reales, Limy Wong, et al.
Annals of the Rheumatic Diseases
|
October 10, 2009
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis
Paul A Lyons, Eoin F McKinney, Tim F Rayner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2004
Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2
Alexander D Barrow, Emmanuelle Astoul, Andres Floto, et al.
The Journal of Experimental Medicine
|
March 26, 2008
Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb
Rebecca J Brownlie, Kate E Lawlor, Heather A Niederer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 24, 2004
Lymphomagenesis, hydronephrosis, and autoantibodies result from dysregulation of IL-9 and are differentially dependent on Th2 cytokines
Angus J Lauder, Helen E Jolin, Philippa Smith, et al.
Gut
|
April 29, 2019
A blood-based prognostic biomarker in IBD
Daniele Biasci, James C Lee, Nurulamin M Noor, et al.
Journal of Crohn'S & Colitis
|
October 22, 2025
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial
Nurulamin M Noor, Neil Davies, Warda Tahir, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 166) with videos related to
Sort By:
Page
of 17
The Journal of Experimental Medicine
|
April 1, 2022
miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease
Carlos Perez-Sanchez, Ariana Barbera Betancourt, Paul A Lyons, et al.
Nature Immunology
|
February 27, 2007
FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis
Zou Xiang, Antony J Cutler, Rebecca J Brownlie, et al.
BMC Medical Genetics
|
March 7, 2009
Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis
Edward J Carr, Menna R Clatworthy, Christopher E Lowe, et al.
Genome Medicine
|
November 26, 2020
Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases
Oliver S Burren, Guillermo Reales, Limy Wong, et al.
Annals of the Rheumatic Diseases
|
October 10, 2009
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis
Paul A Lyons, Eoin F McKinney, Tim F Rayner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2004
Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2
Alexander D Barrow, Emmanuelle Astoul, Andres Floto, et al.
The Journal of Experimental Medicine
|
March 26, 2008
Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb
Rebecca J Brownlie, Kate E Lawlor, Heather A Niederer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 24, 2004
Lymphomagenesis, hydronephrosis, and autoantibodies result from dysregulation of IL-9 and are differentially dependent on Th2 cytokines
Angus J Lauder, Helen E Jolin, Philippa Smith, et al.
Gut
|
April 29, 2019
A blood-based prognostic biomarker in IBD
Daniele Biasci, James C Lee, Nurulamin M Noor, et al.
Journal of Crohn'S & Colitis
|
October 22, 2025
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial
Nurulamin M Noor, Neil Davies, Warda Tahir, et al.
Page
of 17